Clinical Trial Update: Collaborative H1N1 Adjuvant Treatment (CHAT) Pilot Trial [Phase 2]

View source ↗

Summary

The CHAT pilot trial, a Phase 2 study of adjuvant treatment for H1N1 influenza, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• H1n1 Influenza

Snippet

Sponsor: Canadian Critical Care Trials Group | Conditions: H1N1 Influenza | Phase 2 | Status: TERMINATED